(2S) -6-[ (1S,5R,6S) -6- (2,4-Dihydroxybenzoyl) -5- (2,4-dihydroxyphenyl) -3- (4-methylpent-3-enyl) cyclohex-2-en-1-yl]-2- (2,4-dihydroxyphenyl) -5,7-dihydroxy-2,3-dihydrochromen-4-one

CAT:
1410-M38336-01
Size:
100 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
(2S) -6-[ (1S,5R,6S) -6- (2,4-Dihydroxybenzoyl) -5- (2,4-dihydroxyphenyl) -3- (4-methylpent-3-enyl) cyclohex-2-en-1-yl]-2- (2,4-dihydroxyphenyl) -5,7-dihydroxy-2,3-dihydrochromen-4-one - image 1

(2S) -6-[ (1S,5R,6S) -6- (2,4-Dihydroxybenzoyl) -5- (2,4-dihydroxyphenyl) -3- (4-methylpent-3-enyl) cyclohex-2-en-1-yl]-2- (2,4-dihydroxyphenyl) -5,7-dihydroxy-2,3-dihydrochromen-4-one

  • Description:

    Sanggenon G is a cell-permeable and potent inhibitor of X-linked inhibitor of apoptosis protein (XIAP) . Sanggenon G binds specifically to the BIR3 domain of XIAP with a binding affinity of 34.26 μM. Sanggenon G enhances caspase activation.
  • Stability:

    ≥ 2 years
  • Purity:

    >98% (HPLC)
  • Weight:

    694.72
  • Molecular Formula:

    C40H38O11
  • Notes:

    Research use only, not for human use.
  • Receptor:

    Other Targets
  • CAS Number:

    85698-31-3